CIPLA FINASTERIDE 1 finasteride 1 mg film-coated tablet blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

finasteride, Quantity: 1 mg

Disponible depuis:

Cipla Australia Pty Ltd

forme pharmaceutique:

Tablet, film coated

Composition:

Excipient Ingredients: lactose monohydrate; magnesium stearate; maize starch; sodium starch glycollate type A; silicon dioxide; docusate sodium; sodium benzoate; titanium dioxide; hypromellose; macrogol 6000; iron oxide red

Mode d'administration:

Oral

Unités en paquet:

30, 90, 15

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

CIPLA FINASTERIDE 1 is indicated for the treatment of male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss in men 18 years or older. Efficacy has not been demonstrated in men over the age of 41 years.,CIPLA FINASTERIDE 1 is not indicated for use in women (see Use in Pregnancy and Clinical Studies) or children.

Descriptif du produit:

Visual Identification: Tan coloured film coated, biconvex octagonal tablets debossed with '1' on one side and 'SZ' on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2014-07-09